Emma Andrus, Assistant Editor

This Alopecia Awareness Month, we want to know your thoughts on necessary action points to improve alopecia awareness. Click here to answer this week's poll.

Keep up with the latest headlines in dermatology from the past week, including awareness efforts following singer Jimmy Buffett's death from complications of Merkel cell carcinoma, AI dermatology tools lacking representation of darker skin tones, and more.

The condition may present as a manifestation of pediatric rosacea.

BTA treatment was both safe and effective in male and female patients, indicating its potential as a therapeutic strategy in treating Egyptian patients with AGA.

The VIOLIN study examined the burden of disease, prevalence, and treatment of vitiligo in patients in France.

PRP is both safe and effective and may be used as a therapeutic option or alternative in conditions like vitiligo or in wound healing.

Dermatology Times is reflecting on this summer's dermatology conferences with a recap of our top 3 articles from Fall Clinical, Maui Derm, World Congress, SDPA, and SPD.

This Skin Care Awareness Month, Dermatology Times wants to hear your insights. Click here to answer this week's poll.

Keep up with the latest headlines in dermatology from the past week, including excimer laser market projections, an innovative skin health app developed by a California teenager, and more.

Quality of life and sexuality were somewhat affected in 51.9% of adults who had been diagnosed with vulvar lichen sclerosus in childhood or adolescence.

Both modalities achieved positive results and accurate ablation in cultured epithelial sheets transplantation for patients with vitiligo.

Patricia Farris, MD, and Ted Lain, MD, MBA, co-chairs of the Science of Skincare Summit, discuss their excitement for the September conference and its innovative educational experience.

The procedure was both effective and safe in a small cohort of patients with refractory hidradenitis suppurativa of the axilla.

As Hair Loss Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top hair loss headlines and news from August.

Allergan Aesthetics has shared details of a recently-published analysis involving patient-reported satisfaction, including natural-looking outcomes, with OnabotulinumtoxinA (Botox) treatment.

As Psoriasis Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top psoriasis headlines and news from August.

Investigators recommended further studies exploring the confounding variables that may contribute to higher rates of skin cancers in this patient population.

A study found that a triple combination cream containing isobutylamido-thiazolyl-resorcinol, retinoic acid, and dexamethazone proved to be effective in treating melasma.

This Hair Loss Awareness Month, let us know your experiences. Click here to answer this week's poll.

Keep up with the latest headlines in dermatology from the past week, including growing concerns of a dermatologist shortage in Ontario, LEO Pharma's acquisition of Timber Pharmaceuticals, and more. This week, we have also included a patient-forward rundown of top headlines to share with your patients.

The OCCUPES study examined the patient burden associated with foot dermatoses and work-related skin diseases and the implications of a prevention program.

As few as 90% of study participants without visible actinic keratosis lesions displayed inflammatory reactions indicative of the presence of subclinical AK lesions.

The novel therapeutic approach may be promising for patients with the mast cell-dependent disease, which has limited treatment options despite the substantial burden associated with the condition.

While botulinum toxin has emerged as a treatment course for rosacea in recent years, researchers are calling for more comprehensive and detailed long-term research to assess its effectiveness.

Investigators noted that there was not a marked increase, however, in keratinocyte skin carcinomas.

The OX40 monoclonal antibody possesses an extended half-life. In a previous study, this half-life exceeded that of the average conventional IgG.

Keep up with the latest headlines in dermatology from the past week, including the use of skin allografts in treating victims of the Maui wildfires and ways to help victims, and more.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and National Psoriasis Foundations President and CEO Leah Howard, JD, discusses the importance of advocacy and mental health in chronic skin conditions.

UV exposure or trauma to the skin, such as blistering and ulceration, can lead to changes in skin pigmentation and appearance. 

The DERMACLEAR study has retrospectively obtained data from more than 54,000 patients, and the NLP system had greater than 95% precision.